...
首页> 外文期刊>Oral oncology >Whither screening for oral cancer?
【24h】

Whither screening for oral cancer?

机译:还需要筛查口腔癌吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Recent advances in molecular biology have established not only that the sequential progression of the -multipath, mul-tifocal and multicLonal oral carcinogeneic continuum may extend over periods up to two or more decades in duration prior to the initial clinical presentation of occult oral squa-mous cell carcinomas (OSCC), but also that the differential capacity to form distant metastases is already established at the initial precancerous (intraepithelial neoplastic [IEN]) stage. As preventive, especially chemopreventive, measures offer the potential to delay, arrest or even reverse the development of the IEN stages of this continuum, the most rational strategy to reduce the burden of the more than 300,000 new cases of OSCC detected annually worldwide on patients and their families together with the associated economic costs for the provision of healthcare and loss of human capital from their high morbidity and premature mortality rates, centers on the development of techniques for the early detection of individuals at high-risk for oral carcinoeenesis.
机译:分子生物学的最新进展不仅确定了-多径,多聚焦和多克隆口腔致癌基因连续体的连续进展可能会持续长达隐匿性口腔鳞状细胞癌的临床表现之前的两个或更多个时期。细胞癌(OSCC),但形成远处转移的能力已经在癌前期(上皮内瘤变[IEN])初期确立。作为预防措施,尤其是化学预防措施,有可能延迟,阻止甚至逆转此连续体的IEN阶段的发展,这是减轻全球每年在患者和患者中发现的300,000多例新的OSCC病例负担的最合理策略。他们的家人以及因其高发病率和过早死亡率而提供医疗保健和人力资本损失的相关经济成本,集中于早期发现高风险口腔癌患者的技术的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号